Logo

Celgene

Pulmonary Fibrosis Foundation, Celgene Form Biomarker Consortium

The consortium aims to develop assays that can detect biomarkers of pulmonary fibrosis that can be used as early indicators of a treatment's activity.

Evotec, Celgene Partner on Targeted Protein Degradation for Drug Discovery

The collaboration will involve Evotec's Panomics platform, which integrates the analysis of genomic, transcriptomic, and proteomic data.


NIH Launches Parkinson's Disease Research Partnership

The partnership includes biopharmaceutical, life science, and non-profit organizations, as well as several US government agencies.

ArcherDx to Develop CDx for Celgene's Lymphoma Drug Candidate

The companion diagnostic will leverage ArcherDx's Anchored Multiplex PCR technology, Illumina's MiSdqDx sequencer, and Archer Analysis bioinformatics software. 

NIH Partners With Biopharmaceutical Firms on $215M Cancer Immunotherapy Research Initiative

The alliance's first aim is the identification, development, and validation of biomarkers of cancer and treatment response.

Aug 1, 2017

Abbott Receives FDA Approval for IDH2 Mutation CDx Alongside AML Drug

May 31, 2017

IMIDomics, Celgene Partner on Immune-Mediated Inflammatory Disease Research

Dec 7, 2016

GNS Healthcare Expects Increased Biopharma Interest in Causal Machine-Learning Tech
Premium

Dec 5, 2016

Celgene, Dana-Farber, University of Arkansas Form Myeloma Genome Project

Nov 30, 2016

Penn Cancer Center Taps Tempus to Identify Immunotherapy Response Indicators

Oct 24, 2016

Precision Medicine Master Trial Aims to Tailor Therapy for Acute Myeloid Leukemia Patients
Premium

Oct 12, 2016

Abbott Inks CDx Development, Commercialization Deals With Celgene, Agios

May 24, 2016

Novartis, Foundation Medicine, Celgene Invest in Healthcare Informatics Firm COTA

Jan 28, 2016

Human Longevity Acquires Stem Cell Banking Business Unit from Celgene

Oct 23, 2015

MED-C Launches First Registry in NSCLC With Funding Agreements from Pharma, Sequencing Companies
Premium

Mar 2, 2015

UAMS Myeloma Institute to Create MDx Center, Endowed Chair with $10M Celgene Gift

Aug 11, 2014

Human Longevity, Celgene Cellular Therapeutics Ink Deal for Placental Cell Population

Jun 4, 2014

NanoString to Develop Companion Dx for Celgene Lymphoma Drug Study

Dec 4, 2013

NYC, Corporate Partners Launch $100M Life Sciences Investment Fund

Sep 25, 2013

Agios Begins Studying AG-221 for IDH2-Mutated Hematologic Cancer in Phase I Dosing Trial
Premium

Oct 17, 2012

Acceleron Exploring New Biomarker Leads to Personalize Treatment for Breast, Head and Neck Cancers
Premium

Aug 15, 2012

Epic Sciences Developing CTC-based CDx with Drug Firms

May 22, 2012

Smithsonian Museum to Launch Genomics Exhibit Supported by Life Technologies Foundation

May 16, 2012

With Celgene Partnership Epizyme Hopes to Accelerate Personalized Epigenetic Drug Development
Premium

Nov 10, 2011

Startup Quanticel, Fresh off $45M Celgene Deal, Using Fluidigm Tech in Single-Cell Genomic Analyses
Premium

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.